Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with 213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors

Andreas Helisch, Clemens Kratochwil, Christian Kleist, Susanne Krämer, Juan Jose Rosales Castillo, Katharina Dendl, Hendrik […]

2025-10-15T23:19:59+00:003, Dec 2024|Publications|

Imaging Cancer through the Stroma – FAPI PET/CT, a Novel Tracer in Oncology

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2024 ATAWM and CCSNMMI Michigan Road Show […]

2025-11-03T16:19:53+00:009, Nov 2024|Webinars|

FAPI-PET imaging & theranostics: A new era in targeting cancer and fibrotic diseases

Presented by: John Babish – Ratio Therapeutics, Sherly Mosessian, PhD – SOFIE Chief Scientific Officer, […]

2025-11-03T16:19:55+00:007, Nov 2024|Webinars|

Impact of fat intake on [18F]AIF-NOTA-FAPI-04 uptake in normal abdominal organs

Jiashun Dai, Wanjing Zhou, Huaping Liu, Chengzhi Jiang, Hui Ye

2025-10-15T16:39:31+00:007, Nov 2024|Publications|

Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models

Kaori Abe, Tadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, Sadahiro Naka, Kazuhiro Ooe, Atsushi […]

2025-10-13T13:37:25+00:0028, Oct 2024|Publications|

Focus on FAPI Newsletter – Q3 2024

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI […]

2025-12-03T20:09:40+00:004, Sep 2024|Newsletter|

99mTc-HFAPi SPECT imaging predicts left ventricular remodeling after acute myocardial infarction

Cuncun Hua, Xiao-Ying Xi, Yeping Zhang, Ni Suo, Bin Tu, Ye Liu, Xiaoyan Yang, Xiaoyan […]

2025-10-13T13:37:36+00:004, Aug 2024|Publications|

Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Lukas Kessler, Felix Schwaning, Martin Metzenmacher, Kim Pabst, Jens Siveke, Marija Trajkovic-Arsic, Benedikt Schaarschmidt, Marcel […]

2025-10-15T16:40:45+00:001, Aug 2024|Publications|

SOFIE and GE HealthCare SNMMI Symposium highlights FAP targeting

June 9, 2024 (Toronto, CA) –  SNMMI annual meeting attendees had the opportunity to learn […]

2025-10-15T16:42:10+00:0012, Jun 2024|News|

[68Ga]FAPI-46 Phase 2 clinical development updates

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2024 Annual SNMMI Meeting – Toronto, Canada
June […]

2025-11-03T16:04:05+00:009, Jun 2024|Presentations|
Go to Top